- Issuer ticker
-
KNSA
- Reported as of
-
13 Nov 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
17 Nov 2026, 16:36:02 UTC
Filing notes and source
Key filing fact
John F. Paolini filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 17 Nov 2026.
Key facts
- This page summarizes John F. Paolini's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
- 10 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 17 Nov 2026, 16:36.
Change
- Previous filing in this sequence was filed on 03 Nov 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001741533
Primary reporting owner
Paolini John F.
- Relationship
-
CHIEF MEDICAL OFFICER
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +29,670
- Change %
- +42%
- Price
-
$10.36*
- Shares after
- 99,592
- Date
- 13 Nov 2026
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +4,994
- Change %
- +5%
- Price
-
$11.10*
- Shares after
- 104,586
- Date
- 13 Nov 2026
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +3,723
- Change %
- +3.6%
- Price
-
$11.97*
- Shares after
- 108,309
- Date
- 13 Nov 2026
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +3,144
- Change %
- +2.9%
- Price
-
$12.97*
- Shares after
- 111,453
- Date
- 13 Nov 2026
- Ownership
- Direct
KNSA
transaction
Class A Ordinary Share
Options Exercise
- Transaction value
- Shares
- +2,595
- Change %
- +2.3%
- Price
-
$15.52*
- Shares after
- 114,048
- Date
- 13 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- Shares
- -29,670
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 29,670
- Exercise price
- $10.36
- Footnotes
- F1
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- Shares
- -4,994
- Change %
- -8.3%
- Price
-
$0.000000*
- Shares after
- 54,936
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 4,994
- Exercise price
- $11.10
- Footnotes
- F1
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- Shares
- -3,723
- Change %
- -6.2%
- Price
-
$0.000000*
- Shares after
- 56,207
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 3,723
- Exercise price
- $11.97
- Footnotes
- F1
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- Shares
- -3,144
- Change %
- -7.6%
- Price
-
$0.000000*
- Shares after
- 38,256
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 3,144
- Exercise price
- $12.97
- Footnotes
- F1
KNSA
transaction
Derivative
Share Option
Options Exercise
- Transaction value
- Shares
- -2,595
- Change %
- -5.2%
- Price
-
$0.000000*
- Shares after
- 47,405
- Date
- 13 Nov 2026
- Ownership
- Direct
- Underlying class
- Class A Ordinary Share
- Underlying amount
- 2,595
- Exercise price
- $15.52
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote